A study of Ipragliflozin and Phentermine in obese perimenopausal and menopausal women for weight control

Trial Profile

A study of Ipragliflozin and Phentermine in obese perimenopausal and menopausal women for weight control

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 24 Nov 2017

At a glance

  • Drugs Ipragliflozin (Primary) ; Phentermine (Primary)
  • Indications Obesity
  • Focus Therapeutic Use
  • Most Recent Events

    • 24 Nov 2017 New trial record
    • 14 Oct 2017 Preliminary results presented at the North American Menopause Society 2017 Annual Meeting
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top